Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

115

Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

Tags:

Previous Article

Parkinson’s disease pathogenesis from G6PD deficiency

Treating metabolic diseases with microbes containing peptides

Related Posts

High-resolution functional mapping of RAD51C by saturation genome editing

High-resolution functional mapping of RAD51C by saturat...

99

The exocyst subunit EXOC2 regulates the toxicity of expanded GGGGCC repeats in C9ORF72-ALS/FTD

The exocyst subunit EXOC2 regulates the toxicity of exp...

100

VSIG10L is a major determinant of esophageal homeostasis and inherited predisposition to Barrett’s esophagus

VSIG10L is a major determinant of esophageal homeostasi...

36